New genomic test could spare some people with melanoma from lymph node biopsy surgery

A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes—a finding that could guide treatment decisions and help many people avoid lymph node biopsy surgery. The study results are published in JAMA Surgery.

Watch these carnivorous bats create cuddle balls | Science News
- Raunchy, Unrated Netflix Original Is The Pinnacle Of Mockumentary Filmmaking - Robert Scucci
- Best Side Hustles and Service Businesses with Financial Analysis & Investment Strategy Skills - Zoul
- Man with world's longest name re-affirmed by Guinness
- Experiences of disability after 50: Poll looks at self-identity and help with health care visits
- Piers Morgan Explodes at Prince Harry, Calls Him ‘Drug-Addled Little Twerp’ After Explosive BBC Interview - Isaiah Amos
- How to improve your smartphone photography - Steve Dent

I Keep Buying This Stock (I Bought More Today)
- FDA slows down on drug reviews, approvals amid Trump admin chaos - Beth Mole
- Decoding the Enigma of the Snowball Earth - Arya Chandran
- McDonald's is bringing back Monopoly after more than 10 years, this time with new twist
- Where To Start Watching Gundam - Chris Snellgrove
- How a Rectal Cancer Diagnosis Brought This Married Couple Closer Together - Colleen Murphy
- WATCH: Reform UK Mayor STORMS OUT of Interview After BRUTAL GRILLING – Political KNIVES Are OUT in Shock Showdown - Isaiah Amos